KuCoin Expands Stock Index Perpetual Contracts With New Listings

TheNewsCrypto2026-03-19 tarihinde yayınlandı2026-03-19 tarihinde güncellendi

Özet

KuCoin, a leading global cryptocurrency platform, has expanded its lineup of stock index perpetual contracts with the addition of six new trading pairs: CRCLUSDT, COINUSDT, HOODUSDT, INTCUSDT, AMZNUSDT, and PLTRUSDT. This move broadens the platform's equity-linked derivatives offerings, providing eligible users with more cross-asset trading opportunities in a 24/7 crypto market environment. The announcement includes a reminder that these are synthetic, stablecoin-settled derivative products that track equity benchmarks and do not represent actual ownership of securities. Access may be restricted in some jurisdictions, and trading carries significant risk, including the potential loss of the entire margin.

KuCoin, a leading global crypto platform built on trust, today announced the expansion of its Stock Index Perpetual Contracts lineup with six new additions in the latest batch. CRCLUSDT,COINUSDT,HOODUSDT,INTCUSDT,AMZNUSDT, andPLTRUSDT are now live for trading on KuCoin. The expansion further broadens KuCoin’s equity-linked derivatives offering, giving eligible users more ways to access cross-asset trading opportunities in a 24/7 crypto-native market environment.

About KuCoin

Founded in 2017, KuCoin is a leading global crypto platform trusted by over 40 million users across 200+ countries and regions. The platform delivers innovative digital-asset services, offering access to 1,000+ listed tokens, spot and futures trading, institutional wealth management, and a Web3 wallet.

Recognized by Forbes and Hurun, KuCoin holds SOC 2 Type II and ISO 27001:2022 certifications, underscoring its commitment to top-tier security. With AUSTRAC registration in Australia and a MiCA license in Austria, KuCoin continues expanding its regulated footprint under CEO BC Wong, building a reliable and trusted digital-asset ecosystem.

  • Learn more:www.kucoin.com

*Important Notice:

  • These contracts are synthetic derivative products designed to track the price movements of certain publicly available equity benchmarks. They are stablecoin-settled perpetual derivative contracts and do not represent ownership of any stocks or securities, and no shares will be delivered.
  • Access to these products may not be available in certain jurisdictions and may be restricted based on applicable laws and platform compliance requirements. Trading derivatives involves significant risk, including the potential loss of your entire margin. If you have any questions, please seek independent advice. Before trading, please review the Terms of Use, Futures Services Terms, and Risk Disclosure Statements (as updated from time to time).

Disclaimer: TheNewsCrypto does not endorse any content on this page. The content depicted in this Press Release does not represent any investment advice. TheNewsCrypto recommends our readers to make decisions based on their own research. TheNewsCrypto is not accountable for any damage or loss related to content, products, or services stated in this Press Release.

TagsKuCoinPress Release

İlgili Sorular

QWhat new stock index perpetual contracts has KuCoin recently added?

AKuCoin has added six new stock index perpetual contracts: CRCLUSDT, COINUSDT, HOODUSDT, INTCUSDT, AMZNUSDT, and PLTRUSDT.

QWhat type of products are these new KuCoin contracts and how are they settled?

AThese contracts are synthetic derivative products, specifically stablecoin-settled perpetual derivative contracts. They are designed to track the price movements of certain publicly available equity benchmarks.

QDo these perpetual contracts represent ownership of the underlying stocks?

ANo, these contracts do not represent ownership of any stocks or securities, and no shares will be delivered.

QWhat is one of the main benefits for users with this expansion, according to the announcement?

AThe expansion gives eligible users more ways to access cross-asset trading opportunities in a 24/7 crypto-native market environment.

QWhat certifications and regulatory licenses does KuCoin hold, as mentioned in the article?

AKuCoin holds SOC 2 Type II and ISO 27001:2022 certifications. It is also registered with AUSTRAC in Australia and holds a MiCA license in Austria.

İlgili Okumalar

Banks Battle Stablecoins: Where Will Deposits Ultimately Flow?

"Banks vs. Stablecoins: Where Will Deposits Flow?" By: Prathik Desai The traditional banking model, where banks profit from lending out low-interest deposits, faces a fundamental challenge from blockchain-based stablecoins. While U.S. savings accounts offer ~0.6% interest, stablecoins provide near-instant, low-cost global transfers and, via DeFi protocols, access to 5-8% yields. This threatens bank deposit bases and their net interest margins. History offers a parallel: In the 1970s, Merrill Lynch's Cash Management Account (CMA) circumvented Regulation Q's interest caps by sweeping funds into money market funds, causing massive deposit outflows until banks responded with their own high-yield accounts. Today, two competing "digital dollar" models are emerging: 1. **Stablecoins (e.g., USDC):** Funds leave the banking system to back the tokens. While laws like the GENIUS Act forbid issuers from paying interest, users can earn yield via DeFi. This poses an existential threat, especially to regional banks. Predictions suggest significant deposit migration to stablecoins. 2. **Tokenized Deposits:** Banks convert deposits into on-chain tokens for fast, cheap transfers, while the original funds remain on their balance sheets, protected by FDIC insurance and available for lending. Two major bank consortia are developing platforms: one for institutions (led by JPMorgan, Citi, etc.) and Cari Network (regional banks) for retail users. The competition centers on control. Stablecoins offer openness and programmability but lack insurance. Tokenized deposits offer safety and yield but within the traditional, regulated system. A third path, exemplified by SoFi Bank's launch of SoFiUSD, aims to bridge this divide. SoFi integrates a stablecoin, a tokenized deposit (with yield and FDIC insurance), and a bank account in one app, allowing seamless switching based on the user's need for yield, safety, or liquidity. The core insight is that the future belongs not to a single product form, but to the *ability to frictionlessly switch* between forms—optimizing for security, yield, or liquidity as needed. Blockchain technology is becoming financial infrastructure, not to replace banks, but to force them to deconstruct and rebuild their services. The ultimate winners will be institutions that enable this seamless conversion, forcing an evolution similar to the post-Regulation Q era, where traditional finance absorbed innovations to survive.

Foresight News11 dk önce

Banks Battle Stablecoins: Where Will Deposits Ultimately Flow?

Foresight News11 dk önce

Exclusive | ByteDance's AI Drug Discovery Unit Initiates Spinoff and Funding, AI4S Enters Industrialization Phase

Exclusive | ByteDance’s AI Drug Discovery Unit Initiates Spin-off for Financing, Signaling Industrialization Phase for AI4S. ByteDance’s AI drug discovery business line has begun the process of spinning off as an independent entity to raise outside funding, marking a key step toward industrializing its AI for Science (AI4S) efforts. Post-spin-off, ByteDance will remain the controlling shareholder. The new company will inherit the core team, algorithms, technology platform, and existing pipeline assets. It will also continue to receive computing power support from ByteDance's Volcano Engine. The AI drug discovery team, established in 2021 and led by Liu Kai with a core team of about 50 AI and pharmaceutical experts, has been responsible for foundational model research and industrialization. It has consolidated ByteDance's protein structure prediction model team and launched several key technologies. These include the molecular structure prediction models Protenix and Seedfold, the protein design tool PXDesign, and the AI drug discovery platform "Anew Labs." Anew Labs has produced research covering protein-ligand dynamics, molecular generation, and free energy calculation, and has developed early-stage drug pipelines like IL-17 and IL4R inhibitors. Notably, its IL-17 small molecule program, presented in April 2026, demonstrated the first small-molecule blockade of three IL-17 dimers, a significant step in autoimmune disease research. This progress demonstrates ByteDance’s AI capabilities have advanced from model development to validating specific drug targets and molecules. The company believes the opportunity to transition from research to industry is now ripe. The spin-off aims to establish an organizational structure better suited to the business's unique needs—long R&D cycles and complex validation processes involving wet labs and clinical trials—to attract top talent and drive deeper integration of AI with the pharmaceutical industry. The move responds to the pharmaceutical industry's pressing need to improve efficiency amid high R&D costs, long timelines, and high failure rates. The field of AI4S is rapidly advancing, as seen with tools like AlphaFold evolving from protein prediction to modeling complex biological interactions and the emergence of multimodal molecular generation models for drug design. ByteDance has been building its AI4S capabilities for years, exploring areas like computational biology, molecular simulation, and materials science. This spin-off represents its first major attempt to industrialize AI4S. An insider stated the company attaches great importance to this move, hoping that an independent entity with greater decision-making flexibility can pioneer a viable industrial path for AI4S in China.

marsbit49 dk önce

Exclusive | ByteDance's AI Drug Discovery Unit Initiates Spinoff and Funding, AI4S Enters Industrialization Phase

marsbit49 dk önce

Galaxy Deep Dive: How Does Hyperliquid's HIP-4 Upgrade Change the Predictive Markets Landscape?

Galaxy Research Report: How Hyperliquid's HIP-4 Upgrade Changes the Prediction Market Landscape. Hyperliquid's HIP-4 protocol upgrade, activated on May 2, introduces a third model for prediction markets. While incumbents like Polymarket focus on consumer discovery and Kalshi on regulated US access, HIP-4 integrates outcome markets directly into Hyperliquid's "house of all finance." This embeds binary event contracts within HyperCore, its native on-chain order book, sharing a single margin account with perpetual and spot trading. HIP-4 offers distinct advantages: superior infrastructure with sub-second finality, ~200k orders/sec throughput, and unified cross-margin, enabling novel hedges for perpetual traders. It also features a unique validator-curated oracle model for off-chain events (e.g., Fed decisions, CPI, sports) and zero fees on opening positions. Early traction shows HIP-4 capturing ~20% of combined BTC prediction market volume within 25 days. The report highlights a broader industry trend of convergence: all major platforms are moving towards a "trade everything from one account" model. HIP-4's challenge lies in expanding market breadth and consumer discovery, currently lagging behind Polymarket's flexible UMA oracle/Kalshi's sports depth. Key risks include validator centralization, US regulatory exposure (mitigated by potential pathways like the CLARITY Act), and competitive pressure from Kalshi's newly CFTC-approved Bitcoin perpetual contract. Ultimately, HIP-4's strongest case is its technically superior, unified execution stack—a harder advantage for competitors to replicate than building consumer layers atop it. The upgrade positions Hyperliquid to contest the lucrative institutional hedging flow in the evolving prediction market arena.

marsbit2 saat önce

Galaxy Deep Dive: How Does Hyperliquid's HIP-4 Upgrade Change the Predictive Markets Landscape?

marsbit2 saat önce

İşlemler

Spot
Futures
活动图片